University of Liege | Version française
Academic year 2014-2015Value date : 12/05/2015
PHAR0356-1  Industrial Pharmacotechnics including BPF

Duration :  10h Th
Number of credits :  
Master in Pharmacy, Professional Focus in Creation and Development of medicines - bio-analysis, 2nd year2
Lecturer :  Brigitte Evrard, Philippe Hubert
Language(s) of instruction :  
French language
Organisation and examination :  
Teaching in the first semester, review in January
Course contents :  
The objective of this course is an initiation with the industrial production of the drugs by applying good manufacturing practice (GMP). For practical examples and visits of sites of industrial production, the student will learn the general techniques of manufacture and will be informed of the modern methods of management of quality.
..
Learning outcomes of the course :  
Topics are :
  • GMP and quality assurance
  • Solid preparations:
  • Liquid preparations:
  • Semi-solid preparations
Visits of sites of production: UCB Pharma, SMB Technology, GSK are organized
Prerequisites and co-requisites/ Recommended optional programme components :  
Pharmaceutical Technology and biopharmacy
Planned learning activities and teaching methods :  
Demonstrations and seminaries
Mode of delivery (face-to-face ; distance-learning) :  
Face-to-face lectures
Recommended or required readings :  
  • Pharmacotechnie industrielle - ö 41 - Yves ROSSETTO - I.M.T. Editions, 1998

  • Pharmacie galénique - Bonnes pratiques de fabrication des médicaments - A. LE HIR -
    7ème édition - 1997 - Masson.
Assessment methods and criteria :  
written examination
Work placement(s) :  
Organizational remarks :  
see contact
Contacts :  
Brigitte EVRARD, (Coordonnateur)
Philippe HUBERT .



Home

Bachelors, masters, advanced master et AESS

Lifelong Learning Education

Doctorat (Ph.D.)

Search by teacher

Search by course code and title

Students and Studies Administration - Academic Affairs - Contact : Monique Marcourt, General Director for Education and Training - Developed by SEGI